查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496016

眼科超音波系统的全球市场 - 2024 年至 2029 年预测

Global Ophthalmic Ultrasound Systems Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

眼科超音波系统市场预计将从 2022 年的 27 亿美元增加到 2029 年的 46.7 亿美元，预测期内复合年增长率为 8.16%。

眼科超音波系统是眼科中用于诊断影像和治疗目的的专用医疗设备。这些系统利用高频声波创建眼睛内部结构的详细影像，包括角膜、水晶体、玻璃体和视网膜。当光同调断层扫瞄(OCT) 和眼底摄影等传统影像技术无法充分显示眼睛的内侧混浊或后段时，眼科超音波特别有用。

眼科超音波可以帮助诊断和治疗多种眼科疾病，包括视网膜剥离、眼内肿瘤、玻璃体出血和青光眼。此外，超音波显微镜 (UBM) 是眼科超音波的一种特殊形式，用于对虹膜、睫状体和眼角等眼前节结构进行高解析度成像。眼科超音波系统在眼科疾病的综合评估和治疗中发挥重要作用，有助于改善眼科实践中的患者照护和治疗结果。

市场驱动因素：

光学疾病的增加预计将推动眼科超音波系统市场的成长。

近视、远视、散光和老花眼等光学疾病在全球范围内不断增加，预计将在估计期内推动眼科超音波系统市场的扩张。例如，根据世界卫生组织（WHO）2021年10月的资料，全球整体约有22亿人患有近视和远视疾病，其中约10亿病例是可以预防或治疗的。

此外，世界卫生组织估计，全世界约有 8.26 亿人受到未经治疗的老花眼的影响。屈光不正、老龄化黄斑部病变、白内障和青光眼被认为是世界范围内视力障碍和视力障碍的主要原因，视力丧失影响着各个年龄段的人，尤其是50多岁的人。这些发现突显了全球眼科疾病负担日益加重，推动了对眼科超音波设备市场的需求，这对于诊断此类疾病至关重要。

糖尿病视网膜病变的日益普及预计将增加对眼科超音波系统的需求。

糖尿病视网膜病变的盛行率是未来市场扩张的关键因素之一。例如，根据美国眼科学会的最新资料，2016年全球约有3.87亿糖尿病患者，预计2035年将增加至5.92亿。

此外，糖尿病视网膜病变影响全球约 9,300 万人。 1 型糖尿病患者糖尿病视网膜病变的盛行率为 77.3%，2 型糖尿病患者糖尿病视网膜病变的盛行率为 25.1%。据估计，25-30% 的第 2 型糖尿病患者会出现威胁视力的糖尿病黄斑部水肿。 5-8% 的糖尿病视网膜病变患者需要雷射治疗。

预计北美将占据大部分市场。

意识的提高、可支配收入的增加、老年人口的新兴市场以及眼科疾病的流行等变数正在导致北美市场的扩张。多篇研究报导强调了视觉障碍和其他视觉障碍的优点。

例如，在美国，大约有 1,200 万 40 岁以上的成年人患有无法矫正的视力障碍，其中超过 100 万人被归类为盲人。由于糖尿病和其他慢性病的增加以及美国老年人口的不断增加，预计到 2050 年，盲人人数将飙升至 896 万人。此外，美国疾病管制与预防美国(CDC) 报告称，大约 3% 的 18 岁以下儿童患有视力障碍或失明。

未确诊疾病数量的增加预计将进一步促进市场扩张。

此外，安大略省验光师协会 2021 年 7 月的一篇报导描述了加拿大人口老化对矫正视力优势的影响。报告称，有 120 万加拿大人视力丧失，其中光是安大略省居住466,000 人。

此外，超过 800 万加拿大人（安大略省约 310 万）患有四种基本眼疾之一：老龄化黄斑部病变、青光眼、糖尿病视网膜病变和白内障，可能患有或目前患有视力丧失。眼科疾病领域日益增长的主导地位预计将提高眼科超音波系统的市场份额，从而推动该行业的扩张。

市场开拓：

  • 2024 年 4 月 - 华平投资收购印度最大的眼科设备和人工水晶体製造商 Appasamy Associates 的股份。这是该公司在印度医疗保健领域最大的投资。 Apathamy 强大的研发能力和垂直整合使我们能够以实惠的价格提供产品。
  • 2023 年 2 月 - 日本电产推出 Cube a 眼科手术系统，这是一种新型超音波技术，可提高超音波乳化和手术的安全性。该系统采用陀螺扭转技术设计，是眼科手术设备系列的一个有价值的补充，因为它可以有效地提供超音波能量并保护眼内组织，特别是对于中度白内障。
  • 2022 年 10 月－豪迈以约 1.38 亿欧元（相当于 1.45 亿美元）收购 IZI Medical Product。
  • 2022 年 3 月 - Lumibird Medical 在孟买成立子公司 Lumibird Medical India，以加强 Quantel Medical 和 Elex 产品在印度的销售。该子公司旨在共用超音波平台、眼科雷射以及干眼诊断和治疗设备。

公司产品

  • 平台超音波诊断设备超音波诊断设备它提供多重模式影像，可用于妇产科、循环系统、MSK、重症加护、急诊医学、麻醉和小儿科各个领域。它提供多种成像模式，包括黑白、彩色多普勒、3D/4D、频谱多普勒、弹性成像和针头引导。
  • Ezer 超音波 A/B 扫描仪 EUS-2600 -美国眼科的 Ezer EUS-2600超音波A/B 扫描仪具有多种 TGC 选项、即时影像/视讯撷取、大型 12.1 吋 LCD 触控萤幕显示器和使用者友好的临床功能报告、自动AL 采集、PDF 报告、HDMI 和DICOM 3.0通讯协定等介面以及可容纳 20,000 多个测试的大储存容量。它还具有高清 20MHz B 扫描探头和 Dist-5 浸没法。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球眼科超音波系统市场：依类型

  • 介绍
  • 扫描
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • B扫描
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 复合扫描
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 角膜测厚器
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 超音波生物显微镜（UBM）
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章眼科超音波系统的全球市场：依便携性分类

  • 介绍
  • 可携式眼科超音波系统
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 独立眼科超音波系统
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章全球眼科超音波系统市场：依最终使用者分类

  • 介绍
  • 医院
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 眼科诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章全球眼科超音波系统市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按便携性
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按便携性
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按便携性
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按便携性
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按便携性
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 有竞争力的仪表板

第十章 公司简介

  • Sonomed Escalon
  • Halma plc
  • Appasamy Associates
  • DGH Technology Inc.
  • Ellex Medical Lasers Ltd
  • Quantel Medical
  • Nikon Corporation（Optos Plc）
  • NIDEK CO
  • Micro Medical Devices, Inc.
  • MEDA Co., Ltd.
简介目录
Product Code: KSI061611931

The Global Ophthalmic Ultrasound Systems Market is projected to grow at a CAGR of 8.16% during the forecast period to reach US$4.670 billion by 2029, from US$2.700 billion in 2022.

Ophthalmic ultrasound systems are specialized medical devices used in ophthalmology for diagnostic imaging and therapeutic purposes. These systems utilize high-frequency sound waves to create detailed images of the eye's internal structures, including the cornea, lens, vitreous humor, and retina. Ophthalmic ultrasound is particularly valuable in cases where traditional imaging techniques, such as optical coherence tomography (OCT) or fundus photography, may be insufficient due to factors like opacities in the eye's media or poor visualization of the posterior segment.

Ophthalmic ultrasound can aid in the diagnosis and management of various eye conditions, such as retinal detachment, intraocular tumors, vitreous hemorrhage, and glaucoma. Additionally, ultrasound biomicroscopy (UBM) is a specialized form of ophthalmic ultrasound used for high-resolution imaging of anterior segment structures like the iris, ciliary body, and angle. Ophthalmic ultrasound systems play a crucial role in the comprehensive evaluation and treatment of ocular diseases, contributing to improved patient care and outcomes in ophthalmology practice.

Market Drivers:

Increasing optical disorders are expected to propel the ophthalmic ultrasound systems market growth.

The increasing predominance of optical illnesses like nearsightedness, hyperopia, astigmatism, and presbyopia around the world is predicted to boost the ophthalmic ultrasound systems market expansion within the estimated period. For instance, as per the World Health Organization's data of October 2021, around 2.2 billion people globally endure close or far-off vision disability, approximately 1 billion cases being preventable or however to be tended to.

Besides, the WHO evaluated that around 826 million individuals around the world are influenced by unaddressed presbyopia. Refractive errors, age-related macular degeneration, cataracts, and glaucoma are recognized as the major causes of vision disability and visual impairment all over the world, with vision loss influencing people of different ages, though transcendently those above fifty years of age. These discoveries emphasize the expanding burden of eye illnesses universally, driving the demand for ophthalmic ultrasound devices market, which are pivotal for diagnosing such conditions.

The increasing prevalence of diabetic retinopathy is anticipated to increase the demand for ophthalmic ultrasound systems.

The prevalence of diabetic retinopathy is one of the major causes for the market expansion in the year ahead. For instance, recent data from the American Academy of Ophthalmology indicates that there are around 387 million individuals worldwide living with diabetes mellitus in the year 2016, which is expected to expand to 592 million by 2035.

Additionally, diabetic retinopathy affects approximately 93 million individuals globally. Among individuals with type 1 diabetes, the prevalence of diabetic retinopathy is 77.3%, while for those with type 2 diabetes, it is 25.1%. It is estimated that 25% to 30% of type 2 diabetes patients will develop vision-threatening diabetic macular edema. Laser therapy is required for 5% to 8% of patients with diabetic retinopathy.

North America is expected to hold a substantial portion of the market.

Variables like increasing awareness, rising disposable incomes, a developing elderly populace, and the predominance of eye conditions are growing market extensions within North America. Several research article highlights on the predominance of visual impairment and other visual disorders.

For illustration, there are around 12 million adults that are aged forty and over in the US who have vision loss that cannot be rectified, with over 1 million of them classified as blind. It is anticipated that the number of blind people will surge to 8.96 million by 2050, to a great extent due to the rising predominance of diabetes and other chronic ailments, as well as the elderly population within the United States. Besides, the Centers for Disease Control and Prevention (CDC) report that about 3% of children below the age of 18 years encounter visual impairment or blindness.

The rise in undiagnosed target diseases is additionally anticipated to contribute to market expansion.

Further, the Ontario Association of Optometrists article in July 2021 stated the effect of Canada's aging populace on the predominance of corrected vision. The report shown that 1.2 million Canadians encounter vision loss, with 466,000 dwelling in Ontario alone.

Moreover, over 8 million Canadians, about 3.1 million in Ontario, are influenced by one of the four fundamental eye illnesses (age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts), putting them at the chance of vision loss or now encountering it. The expanding predominance of eye disorders is anticipated to drive share for the ophthalmic ultrasound systems market and hence fuel industry expansion.

Market Developments:

  • April 2024- Warburg Pincus bought a stake in Appasamy Associates, India's largest ophthalmic equipment and intraocular lens manufacturer. This is the largest healthcare sector investment by the firm in India. Appasamy's strong R&D capabilities and vertical integration enable it to offer products at affordable prices.
  • February 2023- NIDEK launched the Cube a Ophthalmic Surgical System, a new ultrasound technology that enhances phacoemulsification and surgical safety. The system, designed with Gyro torsional technology, ensures efficient delivery of ultrasound energy, particularly for moderate cataracts, and protects intraocular tissues, making it a valuable addition to the ophthalmic surgical equipment range.
  • October 2022- Halma purchased IZI Medical Product for approximately EUR 138 million (equivalent to USD 145 million). This acquisition aims to enhance its footprint in various diagnostic and therapeutic procedures.
  • March 2022-Lumibird Medical opened a subsidiary in Mumbai, Lumibird Medical India, to boost sales of Quantel Medical and Ellex products in India. The subsidiary aims to provide a shared range of ultrasound platforms, ophthalmic lasers, and equipment for dry eye diagnosis and treatment.

Company Product:

  • On-platform ultrasound system XBit 90- The XBit 90 is a premium ultrasound system by CHISON Medical Technologies, featuring the latest NIT platform and advanced features such as Shear Wave Elastography, Elastography, SonoCrystal, and strain and strain ratio measurements. It offers multi-modality imaging and can be used in various fields such as OB/GYN, cardiovascular, MSK, critical care, emergency medicine, anesthesia, and pediatrics. The system offers various imaging modes, including B/W, color Doppler, 3D/4D, spectral Doppler, elastography, and needle guidance. It also offers built-in consoles and touchscreen options and can be used for various probe types.
  • Ezer Ultrasonic A/B scanner EUS-2600- The Ezer EUS-2600 Ultrasonic A/B scanner by US Ophthalmic offers multiple TGC options, real-time image/video capture, a large 12.1" LCD touchscreen display, user-friendly clinical reporting, automatic AL acquisition, PDF reports, interfaces like HDMI and DICOM 3.0 protocol, and a massive storage capacity for over 20,000 exams. It also features a high-definition 20MHz B-Scan probe and a Dist-5 immersion method.

Market Segmentation:

Global Ophthalmic Ultrasound Systems Market is segmented and analyzed as below:

By Type

  • A-Scan
  • B-Scan
  • Combined Scan
  • Pachymeter
  • Ultrasound Bio-microscopy (UBM)

By Portability

  • Portable Ophthalmic Ultrasound Systems
  • Standalone Ophthalmic Ultrasound Systems

By End-user

  • Hospitals
  • Ophthalmology Clinics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. A-Scan
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. B-Scan
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Combined Scan
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Pachymeter
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Ultrasound Bio-microscopy (UBM)
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY PORTABILITY

  • 6.1. Introduction
  • 6.2. Portable Ophthalmic Ultrasound Systems
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Standalone Ophthalmic Ultrasound Systems
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY END-USERS

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ophthalmology Clinics
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL OPHTHALMIC ULTRASOUND SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Portability
    • 8.2.3. By End-Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Portability
    • 8.3.3. By End-Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Portability
    • 8.4.3. By End-Users
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Portability
    • 8.5.3. By End-Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Opportunities and Trends
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Portability
    • 8.6.3. By End-Users
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Others
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Sonomed Escalon
  • 10.2. Halma plc
  • 10.3. Appasamy Associates
  • 10.4. DGH Technology Inc.
  • 10.5. Ellex Medical Lasers Ltd
  • 10.6. Quantel Medical
  • 10.7. Nikon Corporation (Optos Plc)
  • 10.8. NIDEK CO
  • 10.9. Micro Medical Devices, Inc.
  • 10.10. MEDA Co., Ltd.